The PRISMA Extension Statement for Reporting of Systematic Reviews Incorporating Network Meta-analyses of Health Care Interventions: Checklist and Explanations

被引:5174
作者
Hutton, Brian [1 ]
Salanti, Georgia [2 ]
Caldwell, Deborah M. [3 ]
Chaimani, Anna [2 ]
Schmid, Christopher H. [4 ]
Cameron, Chris [1 ]
Ioannidis, John P. A. [5 ]
Straus, Sharon [6 ]
Thorlund, Kristian
Jansen, Jeroen P.
Mulrow, Cynthia [7 ]
Catala-Lopez, Ferran [8 ]
Gotzsche, Peter C. [9 ]
Dickersin, Kay [10 ]
Boutron, Isabelle [11 ]
Altman, Douglas G. [12 ]
Moher, David [1 ]
机构
[1] Ottawa Hosp Res Inst, Ctr Practice Changing Res, Ottawa Hosp Gen Campus,501 Smyth Rd,POB 201B, Ottawa, ON K1H 8L6, Canada
[2] Univ Ioannina, Dept Hyg & Epidemiol, Sch Med, Ioannina 45110, Greece
[3] Sch Social & Community Med, Bristol BS8 2PS, Avon, England
[4] Brown Univ, Ctr Evidence Based Med, Sch Publ Hlth, Providence, RI 02912 USA
[5] Stanford Univ, Sch Med, Stanford Prevent Res Ctr, Stanford, CA 94305 USA
[6] St Michaels Hosp, Li Ka Shing Knowledge Inst, Toronto, ON M5B 1W8, Canada
[7] Amer Coll Physicians, Philadelphia, PA 19106 USA
[8] Spanish Med & Healthcare Prod Agcy, Div Pharmacoepidemiol & Pharmacovigilance, Madrid 28022, Spain
[9] Rigshosp, Nord Cochrane Ctr, Dept 7811, DK-2100 Copenhagen, Denmark
[10] Johns Hopkins Bloomberg Sch Publ Hlth, Baltimore, MD 21205 USA
[11] Univ Paris 05, Ctr Epidemiol Clin, INSERM,Equipe Methodes Evaluat Therapeut Malad, Ctr Rech Epidemiol & Stat,Hop Hotel Dieu,U1153, F-75181 Paris 4, France
[12] Univ Oxford, Nuffield Dept Orthopaed Rheumatol & Musculoskelet, Ctr Stat Med, Botnar Res Ctr, Oxford OX3 7LD, England
基金
加拿大健康研究院; 英国医学研究理事会;
关键词
RANDOMIZED CONTROLLED-TRIALS; MIXED TREATMENT COMPARISONS; ISPOR TASK-FORCE; DECISION-MAKING; MULTIPLE-TREATMENTS; INCONSISTENCY; CONSISTENCY; GUIDELINES; QUALITY; MODELS;
D O I
10.7326/M14-2385
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The PRISMA statement is a reporting guideline designed to improve the completeness of reporting of systematic reviews and meta-analyses. Authors have used this guideline worldwide to prepare their reviews for publication. In the past, these reports typically compared 2 treatment alternatives: With the evolution of systematic reviews that compare multiple treatments, some of them only indirectly, authors face novel challenges for conducting and reporting their reviews. This extension of the PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-analyses) statement was developed specifically to improve the reporting of systematic reviews incorporating network meta-analyses. A group of experts participated in a systematic review, Delphi survey, and face-to-face discussion and consensus meeting to establish new checklist items for this extension statement. Cur-rent PRISMA items were also clarified. A modified, 32-item PRISMA extension checklist was developed to address what the group considered to be immediately relevant to the reporting of network meta-analyses. This document presents the extension and provides examples of good reporting, as well as elaborations regarding the rationale for new checklist items and the modification of previously existing items from the PRISMA statement. It also highlights educational information related to key considerations in the practice of network meta-analysis. The target audience includes authors and readers of network meta-analyses, as well as journal editors and peer reviewers.
引用
收藏
页码:777 / 784
页数:8
相关论文
共 58 条
  • [1] Extending methods for investigating the relationship between treatment effect and baseline risk from pairwise meta-analysis to network meta-analysis
    Achana, Felix A.
    Cooper, Nicola J.
    Dias, Sofia
    Lu, Guobing
    Rice, Stephen J. C.
    Kendrick, Denise
    Sutton, Alex J.
    [J]. STATISTICS IN MEDICINE, 2013, 32 (05) : 752 - 771
  • [2] ADES AE, 2010, VALUE HLTH, V784
  • [3] ADES AE, 2012, 7 DSU NAT I HLTH CAR
  • [4] Simultaneous comparison of multiple treatments: combining direct and indirect evidence
    Caldwell, DM
    Ades, AE
    Higgins, JPT
    [J]. BMJ-BRITISH MEDICAL JOURNAL, 2005, 331 (7521): : 897 - 900
  • [5] Using network meta-analysis to evaluate the existence of small-study effects in a network of interventions
    Chaimani, Anna
    Salanti, Georgia
    [J]. RESEARCH SYNTHESIS METHODS, 2012, 3 (02) : 161 - 176
  • [6] Conceptual and Technical Challenges in Network Meta-analysis
    Cipriani, Andrea
    Higgins, Julian P. T.
    Geddes, John R.
    Salanti, Georgia
    [J]. ANNALS OF INTERNAL MEDICINE, 2013, 159 (02) : 130 - W54
  • [7] Addressing between-study heterogeneity and inconsistency in mixed treatment comparisons: Application to stroke prevention treatments in individuals with non-rheumatic atrial fibrillation
    Cooper, Nicola J.
    Sutton, Alex J.
    Morris, Danielle
    Ades, A. E.
    Welton, Nicky J.
    [J]. STATISTICS IN MEDICINE, 2009, 28 (14) : 1861 - 1881
  • [8] Network meta-analysis models to account for variability in treatment definitions: application to dose effects
    Del Giovane, Cinzia
    Vacchi, Laura
    Mavridis, Dimitris
    Filippini, Graziella
    Salanti, Georgia
    [J]. STATISTICS IN MEDICINE, 2013, 32 (01) : 25 - 39
  • [9] Estimation and adjustment of bias in randomized evidence by using mixed treatment comparison meta-analysis
    Dias, S.
    Welton, N. J.
    Marinho, V. C. C.
    Salanti, G.
    Higgins, J. P. T.
    Ades, A. E.
    [J]. JOURNAL OF THE ROYAL STATISTICAL SOCIETY SERIES A-STATISTICS IN SOCIETY, 2010, 173 : 613 - 629
  • [10] Checking consistency in mixed treatment comparison meta-analysis
    Dias, S.
    Welton, N. J.
    Caldwell, D. M.
    Ades, A. E.
    [J]. STATISTICS IN MEDICINE, 2010, 29 (7-8) : 932 - 944